A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.
Also called NCT07030101
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 400 participants
- Sponsor
- EMS
- Registry
-
NCT07030101
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07030101. Randomized; triple masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2029-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension
- Acronym
- TRÍADE-HA
- Condition
- Hypertension
- Intervention (Drug)
- TCA108
- Intervention (Drug)
- Bramicar HCT
- Intervention (Drug)
- Micardis Anlo
- Lead sponsor
- EMS
Record details
- Record id
cardio:ct-nct07030101- Content hash
f147b3cb328a71dd0148c283cce5f38ae34a2232196605217105417bd8098da2